Naoki Takahashi, Hiroki Hara, Hirokazu Shoji, Takayuki Ando, Akitaka Makiyama, Jin Matsuyama, Ryohei Kawabata, Hiroshi Imamura, Keiko Minashi, Yosuke Kito, Takeshi Yamada, Hiroki Osumi, Mitsuhiro Furuta, Kengo Nagashima, Toshihiko Matsumoto, Kenro Hirata, Hisato Kawakami, Kentaro Yamazaki, Shuichi Hironaka, Kei Muro. "The primary results of a randomized phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus FTD/TPI for previously treated patients with advanced gastric or gastroesophageal junction adenocarcinoma (RETRIEVE study, WJOG 15822G).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.357